AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Tobramycin in South Africa
7 products registered with SAHPRA — 4 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| CIPLA-TOBRAMYCIN RESPULES | 44/20.1.1/0049 | Cipla Medpro (Pty) Ltd | suspended | 20 Apr 2026 |
| TOBRAHALE RESPULES | 44/20.1.1/0048 | Cipla Medpro (Pty) Ltd | suspended | 18 Jul 2025 |
| TOBRABACT | 37/15.1/0082 | Adcock Ingram Limited | suspended | 17 Jun 2025 |
| TOBI 300 mg/5 ml | A40/20.1.1/0522 | Viatris South Africa (Pty) Ltd | active | 1 Jan 1900 |
| TOBREX EYE OINTMENT | P/15.1/205 | Novartis South Africa (Pty) Ltd | active | 1 Jan 1900 |
| OCTUDEX | 51/15.3/1074 | Ranbaxy (SA) (Pty) Ltd | active | 1 Jan 1900 |
| TOBREX EYE DROPS | P/15.1/58 | Novartis South Africa (Pty) Ltd | active | 1 Jan 1900 |
Tobramycin — SAHPRA Registration Details
SAHPRA (South Africa) has 7 registered products containing Tobramycin, of which 4 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Tobramycin registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.